Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
Much of the impact of Marek's disease in broiler chickens is considered to be due to immunosuppression induced by Marek's disease virus (MDV). The present study evaluates the effects of an Australian isolate of pathogenic MDV (strain MPF 57) and a non-pathogenic vaccinal strain of herpesvirus of turkeys (HVT) (strain FC 126) on the immune system of commercial broiler chickens for 35 days following challenge at days 0 or 3 of age. It also investigates the extent of protection provided by HVT vaccine against MDV-induced immunosuppression. Immune system variables, including relative lymphoid organ weight, blood lymphocyte phenotype (CD45+/CD3+, putatively T, and CD45+/LC+, putatively B) and antibody production following vaccination against infectious bronchitis (IB) at hatch, were used to assess the immune status of chickens. Immunosuppression was also assessed by susceptibility to secondary challenge with pathogenic Escherichia coli on day 29 post-MDV challenge. MDV infection reduced the weight of the thymus and bursa of Fabricius, the numbers of circulating T lymphocytes and B lymphocytes, and IB antibody titre. The timing of these effects varied. MDV infection greatly increased susceptibility to E. coli infection. HVT alone caused mild depletion of T and B lymphocytes but no effect on immune organ weight or IB titre. Vaccination with HVT provided good protection against most of the immunosuppressive effects of MDV but not against MDV-induced growth impairment and reduced responsiveness to IB vaccination, suggesting that recent Australian strains of MDV may be evolving in virulence to overcome the protective effects of HVT.
Islam
A F M F
AF
Animal Science, School of Rural Science and Agriculture, University of New England, Armidale, NSW 2351 Australia. fislam@metz.une.edu.au
Wong
C W
CW
Walkden-Brown
S W
SW
Colditz
I G
IG
Arzey
K E
KE
Groves
P J
PJ
D000818:Animals; D002645:Chickens; D006566:Herpesviridae Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D026002:Herpesvirus 1, Meleagrid; D008221:Lymphoid Tissue / Q000033:anatomy & histology / Q000187:drug effects / Q000276:immunology; D025922:Mardivirus / Q000276:immunology*; D022501:Marek Disease Vaccines / Q000627:therapeutic use*; D009929:Organ Size / Q000187:drug effects; D011201:Poultry Diseases / Q000276:immunology* / Q000517:prevention & control; D014422:Turkeys; D014611:Vaccination / Q000662:veterinary*
D022501:Marek Disease Vaccines